Patent · US Active

Modulation of thymosin beta-4 in skin

US9114089B2 · kind B2 · utility

0Cited by

4References

6Claims

0Family size

Assignee

Avon Products, Inc. · US

Inventors

Siming W. Chen · Berkeley Heights, US
Qian Zheng · Morristown, US
Satish Parimoo · Bound Brook, US

Key dates

Filing date	Dec 9, 2013
Grant date	Aug 25, 2015
Priority date	—
Expiry date	Dec 9, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/68
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.